Can a common diabetes drug shield teen kidneys from damage?
NCT ID NCT07591077
First seen May 17, 2026 · Last updated Jun 05, 2026 · Updated 2 times
Summary
This study looked at whether a type of diabetes medicine called SGLT2 inhibitors can slow down kidney disease in teenagers with type 1 diabetes. 86 teens took part. The main goal was to see if the drug could reduce a marker of kidney damage (UACR) after 6 months. The study also checked blood sugar control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.